Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase-Reference-Cited by-同舟云学术

Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase

Published:2020-12-08 Issue:1 Volume:7 Page:47-63
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Mina John G. M.¹,Charlton Rebecca L.¹²,Alpizar-Sosa Edubiel³⁴,Escrivani Douglas O.¹²,Brown Christopher¹,Alqaisi Amjed³⁵,Borsodi Maria Paula G.²,Figueiredo Claudia P.⁶,de Lima Emanuelle V.⁶,Dickie Emily A.⁴,Wei Wenbin³,Coutinho-Silva Robson²,Merritt Andy⁷,Smith Terry K.⁸^ORCID,Barrett Michael P.⁴,Rossi-Bergmann Bartira²,Denny Paul W.³,Steel Patrick G.¹^ORCID

Affiliation:

1. Departments of Chemistry, University of Durham, Science Laboratories, South Road, Durham DH1 3LE, United Kingdom

2. Institute of Biophysics Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, Rio de Janeiro, Brazil

3. Department of Biosciences, University of Durham, South Road, Durham DH1 3LE, United Kingdom

4. Wellcome Centre for Integrative Parasitology and Glasgow Polyomics, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom

5. Department of Biology, College of Science, University of Baghdad, Baghdad 10071, Iraq

6. School of Pharmacy, Universidade Federal do Rio de Janeiro, 21944-590 Rio de Janeiro, Rio de Janeiro, Brazil

7. LifeArc, Open Innovation Campus, Stevenage SG1 2FX, United Kingdom

8. BSRC, Schools of Biology and Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, United Kingdom

Funder

Royal Society

Medical Research Council

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico

Wellcome Trust

Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro

Publisher

American Chemical Society (ACS)